186 related articles for article (PubMed ID: 62398)
1. Antinuclear antibodies (ANA): immunologic and clinical significance.
Fernandez-Madrid F; Mattioli M
Semin Arthritis Rheum; 1976 Nov; 6(2):83-124. PubMed ID: 62398
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the complement-fixing activity of antinuclear antibodies in lupus nephritis, mixed connective tissue disease, and scleroderma.
Parker MD; Turner RA
Arthritis Rheum; 1976; 19(5):857-61. PubMed ID: 786297
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of anti-nDNA antibodies in ANA-positive systemic lupus erythematosus: comparison of the Farr radioimmunoassay and the Crithidia luciliae immunofluorescent technique.
Chuan MT; Wu YC; Ang ET; Wang JH; In KL; Lü YC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 Feb; 18(1):15-24. PubMed ID: 3896689
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of IgE antinuclear antibodies in rheumatoid arthritis and systemic lupus erythematosus.
Permin H; Wiik A
Acta Pathol Microbiol Scand C; 1978 Oct; 86C(5):245-9. PubMed ID: 309705
[TBL] [Abstract][Full Text] [Related]
5. Speckled antinuclear antibodies in keratinocytes--what does it mean?
Bukilica MN; Andrejevic SB; Bonaci-Nikolic BM; Nikolic MM
Clin Exp Rheumatol; 2002; 20(4):499-504. PubMed ID: 12175105
[TBL] [Abstract][Full Text] [Related]
6. [Modern look at the problems of investigation of antinuclear antibodies in systemic lupus erythematosus (literature review).].
Aleksandrova EN; Verizhnikova ZG; Novikov AA; Lukina GV
Klin Lab Diagn; 2018; 63(6):340-348. PubMed ID: 30702224
[TBL] [Abstract][Full Text] [Related]
7. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
[TBL] [Abstract][Full Text] [Related]
8. [Sharp's syndrome. Clinical, immunological and nosographic aspects].
Scagliusi P; Muratore M; Martiradonna A; Berlingerio G; Carrozzo M
Minerva Med; 1980 Dec; 71(50):3655-63. PubMed ID: 6161325
[TBL] [Abstract][Full Text] [Related]
9. The use of laboratory tests in the diagnosis of SLE.
Egner W
J Clin Pathol; 2000 Jun; 53(6):424-32. PubMed ID: 10911799
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of systemic lupus erythematosus. Importance of antinuclear antibody titers and peripheral staining patterns.
Nisengard RJ; Jablonska S; Chorzelski TP; Blaszcyk M; Jarret C; Beutner EH
Arch Dermatol; 1975 Oct; 111(10):1298-300. PubMed ID: 54050
[TBL] [Abstract][Full Text] [Related]
11. Analysis of antinuclear antibody titers and patterns by using HEp-2 and primate liver tissue substrate indirect immunofluorescence assay in patients with systemic autoimmune rheumatic diseases.
Wei Q; Jiang Y; Xie J; Lv Q; Xie Y; Tu L; Xiao M; Wu Z; Gu J
J Clin Lab Anal; 2020 Dec; 34(12):e23546. PubMed ID: 33047841
[TBL] [Abstract][Full Text] [Related]
12. The clinical application of an ELISA technique for the detection of antihistone antibodies.
Epstein A; Greenberg M; Halbert S; Kramer L; Barland P
J Rheumatol; 1986 Apr; 13(2):304-7. PubMed ID: 3522897
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic significance of different antinuclear antibodies in more than 1000 consecutive Albanian patients with rheumatic diseases.
Sulcebe G; Morcka K
Clin Exp Rheumatol; 1992; 10(3):255-61. PubMed ID: 1582070
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic approaches in systemic lupus erythematosus (author's transl)].
Häcki MA; Grob PJ
Dtsch Med Wochenschr; 1976 Jan; 101(1):13-6. PubMed ID: 1106979
[TBL] [Abstract][Full Text] [Related]
15. [Specific antibodies of soluble nuclear antigens in autoimmune vasculitis].
Weill BJ; Job-Deslandre C; Menkès CJ; Amor B
Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):453-6. PubMed ID: 3303286
[TBL] [Abstract][Full Text] [Related]
16. Identification of specific antinuclear antibodies in dogs using a line immunoassay and enzyme-linked immunosorbent assay.
Bremer HD; Lattwein E; Renneker S; Lilliehöök I; Rönnelid J; Hansson-Hamlin H
Vet Immunol Immunopathol; 2015 Dec; 168(3-4):233-41. PubMed ID: 26547884
[TBL] [Abstract][Full Text] [Related]
17. Complement fixing activity and immunoglobulin classes of antinuclear antibodies occurring in systemic lupus erythematosus and rheumatoid arthritis.
Massonnet-Castel S; Cassuto JP; Rioche M; Mucchielli A; Masseyeff R
Biomedicine; 1981 Feb; 34(1):40-6. PubMed ID: 6971657
[TBL] [Abstract][Full Text] [Related]
18. Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases.
Strassburg CP; Alex B; Zindy F; Gerken G; Lüttig B; Meyer zum Büschenfelde KH; Bréchot C; Manns MP
J Hepatol; 1996 Dec; 25(6):859-66. PubMed ID: 9007714
[TBL] [Abstract][Full Text] [Related]
19. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.
Wirestam L; Schierbeck H; Skogh T; Gunnarsson I; Ottosson L; Erlandsson-Harris H; Wetterö J; Sjöwall C
Arthritis Res Ther; 2015 Nov; 17():338. PubMed ID: 26596890
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
Yang Z; Ren Y; Liu D; Lin F; Liang Y
APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]